Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

A unique case of aggressive uterine cancer in a 45-year-old man with persistent Müllerian duct syndrome.

Dimasis N, Koukourikis P, Klampatsas A, Xirou P, Sountoulides P.

Arch Esp Urol. 2019 May;72(4):435-438.

PMID:
31070141
2.

International and Multi-institutional Assessment of Factors Associated With Performance and Quality of Lymph Node Dissection During Radical Nephrectomy.

Osterberg EC, Golan S, Pes MPL, Eggener SE, Petrut B, Singh SK, Sountoulides P, Türkeri LN, Wolf JS Jr.

Urology. 2019 Apr 19. pii: S0090-4295(19)30351-6. doi: 10.1016/j.urology.2019.01.068. [Epub ahead of print]

PMID:
31009740
3.

Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction.

Sountoulides P, Karatzas A, Gravas S.

Ther Adv Urol. 2019 Feb 14;11:1756287219828971. doi: 10.1177/1756287219828971. eCollection 2019 Jan-Dec. Review.

4.

Commentary/guest editorial on: "Treatment of fragmented and severely encrusted urethral D-J stent forgotten for 11 years through multimodal endourological methods".

Bourdoumis A, Calleary J, Sountoulides P.

Urol Ann. 2019 Jan-Mar;11(1):113-114. doi: 10.4103/UA.UA_146_18. No abstract available.

5.

Feeling of incomplete bladder emptying: A definition with clinical implications.

Sountoulides P, Mutomba WF.

Low Urin Tract Symptoms. 2019 Jan;11(1):85. doi: 10.1111/luts.12251. No abstract available.

PMID:
30675770
6.

Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience.

Tamburro FR, Castellan P, Neri F, Berardinelli F, Bada M, Sountoulides P, Giuliani N, Finazzi Agrò E, Schips L, Cindolo L.

Urologia. 2018 Nov;85(4):163-168. doi: 10.1177/0391560318759258. Epub 2018 Mar 28.

PMID:
30426883
7.

Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study.

Cindolo L, Spiess PE, Bada M, Chipollini JJ, Nyirády P, Chiodini P, Varga J, Ditonno P, Battaglia M, De Nunzio C, Tema G, Veccia A, Antonelli A, Musi G, De Cobelli O, Conti A, Micali S, Álvarez-Maestro M, Olarte JQ, Diogenes E, Lima MVA, Tracey A, Guruli G, Autorino R, Sountoulides P, Schips L.

World J Urol. 2018 Oct 30. doi: 10.1007/s00345-018-2549-3. [Epub ahead of print]

PMID:
30377813
8.

Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of 'real-life' studies.

Marchioni M, Sountoulides P, Bada M, Rapisarda S, De Nunzio C, Tamburro FR, Schips L, Cindolo L.

Ther Adv Urol. 2018 Jul 10;10(10):305-315. doi: 10.1177/1756287218786160. eCollection 2018 Oct.

9.

Worldwide Use of Antiretropulsive Techniques: Observations from the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.

Saussine C, Andonian S, Pacík D, Popiolek M, Celia A, Buchholz N, Sountoulides P, Petrut B, de la Rosette JJMCH.

J Endourol. 2018 Apr;32(4):297-303. doi: 10.1089/end.2017.0629. Epub 2018 Jan 17.

PMID:
29256629
10.

Bone Imaging in Metastatic Castration-resistant Prostate Cancer; Where do we Stand.

Sountoulides P, Metaxa L.

Curr Radiopharm. 2017 Nov 10;10(3):171-177. doi: 10.2174/1874471010666170816125907. Review.

PMID:
28814252
11.

Non-visible asymptomatic haematuria: a review of the guidelines from the urologist's perspective.

Sountoulides P, Mykoniatis I, Metaxa L.

Expert Rev Anticancer Ther. 2017 Mar;17(3):203-216. doi: 10.1080/14737140.2017.1284589. Epub 2017 Jan 27. Review.

PMID:
28116915
12.

The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma.

Bantis A, Sountoulides P, Metaxa L, Pavlidis P, Aggelonidou E, Arif H, Zisimopoulos A.

Urol Ann. 2016 Oct-Dec;8(4):496-499. doi: 10.4103/0974-7796.192090.

13.

The era of active surveillance for low-risk.Prostate cancer is here.

Sountoulides P, Obek C.

Arch Esp Urol. 2016 Mar;69(2):49-51. No abstract available.

PMID:
27441708
14.

Giant Scrotal Fibrolipoma.

Mykoniatis I, Metaxa L, Nikolaou V, Filintatzi C, Kikidakis D, Sountoulides P.

Rare Tumors. 2015 Dec 29;7(4):6001. doi: 10.4081/rt.2015.6001. eCollection 2015 Dec 29.

15.

Radiological findings and the clinical importance of megacalycosis.

Kalaitzis C, Patris E, Deligeorgiou E, Sountoulides P, Bantis A, Giannakopoulos S, Touloupidis S.

Res Rep Urol. 2015 Oct 19;7:153-5. doi: 10.2147/RRU.S81519. eCollection 2015.

16.

Combination Pharmacological Treatments for LUTS.

Sountoulides P, Apostolidis A.

Curr Drug Targets. 2015;16(11):1162-4. No abstract available.

PMID:
26470798
17.

Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

Cindolo L, Pirozzi L, Sountoulides P, Fanizza C, Romero M, Castellan P, Antonelli A, Simeone C, Tubaro A, de Nunzio C, Schips L.

BMC Urol. 2015 Sep 21;15:96. doi: 10.1186/s12894-015-0090-x.

18.

Palliative management of malignant upper urinary tract obstruction.

Sountoulides P, Mykoniatis I, Dimasis N.

Hippokratia. 2014 Oct-Dec;18(4):292-7. Review.

19.

Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?

Pirozzi L, Sountoulides P, Castellan P, Presicce F, Lombardo R, Romero M, De Nunzio C, Tubaro A, Schips L, Cindolo L.

Curr Drug Targets. 2015;16(11):1165-71. Review.

PMID:
25981606
20.

The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH.

Sountoulides P, Gravas S.

Curr Drug Targets. 2015;16(11):1172-9. Review.

PMID:
25706255

Supplemental Content

Loading ...
Support Center